Forte Biosciences Inc (FBRX)

Currency in USD
17.8800
+0.3200(+1.82%)
Real-time Data·
FBRX is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
17.660018.3500
52 wk Range
9.100035.7999
Key Statistics
Prev. Close
17.56
Open
17.74
Day's Range
17.66-18.35
52 wk Range
9.1-35.7999
Volume
23.66K
Average Volume (3m)
297.95K
1-Year Change
47.952%
Book Value / Share
2.24
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
FBRX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
63.7500
Upside
+256.54%
Members' Sentiments
Bearish
Bullish
ProTips
Significant return over the last week

Forte Biosciences Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Buy
Moving Averages
Buy

Analyst Ratings

5 Buy
0 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 63.7500
(+256.54% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Guggenheim
Buy75.00+319.46%-MaintainApr 02, 2026
Evercore ISI
Buy65.00+263.53%-New CoverageNov 25, 2025
Guggenheim
Buy75.00+319.46%-New CoverageAug 18, 2025
Brookline Capital Markets
Buy54.00+202.01%57.00MaintainAug 15, 2025

Earnings

Latest Release
May 11, 2026
EPS / Forecast
-1.24 / -1.21
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

FBRX Income Statement

Compare FBRX to Peers and Sector

Metrics to compare
FBRX
Peers
Sector
Relationship
P/E Ratio
−5.7x−4.7x−0.5x
PEG Ratio
−0.13−0.030.00
Price/Book
10.2x3.6x2.6x
Price / LTM Sales
-19.8x3.0x
Upside (Analyst Target)
258.8%104.1%58.6%
Fair Value Upside
Unlock−6.9%10.2%Unlock

Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company’s lead product candidate is the FB-102, a proprietary anti-CD122 monoclonal antibody therapeutic candidate for various autoimmune and autoimmune-related indications, such as celiac disease, vitiligo, alopecia areata, and type 1 diabetes. Forte Biosciences, Inc. is headquartered in Dallas, Texas.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
5.07M20.77%89.11M
Other Institutional Investors
15.68M64.18%275.37M
Public Companies & Retail Investors
3.68M15.06%64.61M
Total
24.44M100.00%429.09M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Federated Hermes, Inc.7.23%1,765,51631,002
Fred Alger Management, LLC5.21%1,273,96522,371

People Also Watch

20.650
BBAR
+0.15%
50.94
CYD
+1.82%
68.98
KGS
-0.14%
397.80
MOGa
+0.68%
87.17
XMTR
+0.21%

FAQ

What Is the Forte Biosciences Inc (FBRX) Stock Price Today?

The Forte Biosciences Inc stock price today is 17.8800 USD.

What Stock Exchange Does Forte Biosciences Inc Trade On?

Forte Biosciences Inc is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for Forte Biosciences Inc?

The stock symbol for Forte Biosciences Inc is "FBRX."

What Is the Forte Biosciences Inc Market Cap?

As of today, Forte Biosciences Inc market cap is 433.9800M USD.

What Is Forte Biosciences Inc's Earnings Per Share (TTM)?

The Forte Biosciences Inc EPS (TTM) is -4.6459.

When Is the Next Forte Biosciences Inc Earnings Date?

Forte Biosciences Inc will release its next earnings report on Aug 17, 2026.

From a Technical Analysis Perspective, Is FBRX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Forte Biosciences Inc Stock Split?

Forte Biosciences Inc has split 2 times.

How Many Employees Does Forte Biosciences Inc Have?

Forte Biosciences Inc has 22 employees.

What is the current trading status of Forte Biosciences Inc (FBRX)?

As of Jun 15, 2026, Forte Biosciences Inc (FBRX) is trading at a price of 17.8800 USD, with a previous close of 17.5600 USD. The stock has fluctuated within a day range of 17.6600 USD to 18.3500 USD, while its 52-week range spans from 9.1000 USD to 35.7999 USD.

What Is Forte Biosciences Inc (FBRX) Price Target According to Analysts?

The average 12-month price target for Forte Biosciences Inc is 63.7500 USD, with a high estimate of 75 USD and a low estimate of 54 USD. 5 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +256.54% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.